Five deaths in the UK have been associated with Acomplia (rimonobant)

Posted by .(JavaScript must be enabled to view this email address)
Wednesday, June 04, 2008 6:59 am Email this article
Acomplia (rimonobant) has been cited in 5 deaths and 720 adverse drug reactions in the UK according to figures published on June 3rd, 2008 by the Medicines and Healthcare products Regulatory Agency (MHRA).

One person on the drug committed suicide. Another person died from an infection, while three others died from heart attacks.

The European Union approved Acomplia in 2006. Psychiatric Reactions

Psychiatric reactions made up 44% of adverse reactions

As of the end of January 2008, there had been 673 adverse drug reports and 1971 individual reactions.

Forty-four percent of all of these—876 out of the 1971 reported reactions—were psychiatric reactions.

The most common psychiatric reactions were depression and mood disorders.

 

Suicidal Thoughts

52 reports of thoughts of suicide or self-harming behaviors

Fifty-two (52) reactions involved thoughts of suicide or self-harming behaviors, most of which (42 reports) were thoughts of suicide.

REFERENCE

Drug Safety Update from the UK’s Medicines and Healthcare products Regulatory Agency. 2008 May, Vol. 1, No. 10.
http://www.mhra.gov.uk/Publications/Safetyguidance/DrugSafetyUpdate/CON015025

Sanofi-aventis anti-obesity drug cited by UK regulator in 5 deaths. 2008 Jun 04.
http://www.forbes.com/afxnewslimited/feeds/afx/2008/06/04/afx5078340.html

http://www.mhra.gov.uk/

 

Articles on the same subject can be found here:

• Acomplia (rimonabant)